These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34687492)

  • 1. Absence of large portal collateral vessels is associated with spontaneous improvement of cirrhotic portal vein thrombosis.
    Yokoyama S; Ishizu Y; Honda T; Imai N; Ito T; Yamamoto K; Tsuzuki T; Ishigami M
    Hepatol Res; 2022 Feb; 52(2):199-209. PubMed ID: 34687492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of portal vein thrombosis in liver cirrhosis.
    Qi X; Han G; Fan D
    Nat Rev Gastroenterol Hepatol; 2014 Jul; 11(7):435-46. PubMed ID: 24686266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients.
    Benevento F; Pecorelli A; Stefanescu H; Sparchez Z; Vukotic R; Pettinari I; Grigoras CA; Tovoli F; Ravaioli F; Stefanini B; Andreone P; Piscaglia F
    J Hepatocell Carcinoma; 2023; 10():473-482. PubMed ID: 37007210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis.
    Chen H; Liu L; Qi X; He C; Wu F; Fan D; Han G
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):82-9. PubMed ID: 26513611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system.
    Abdel-Razik A; Mousa N; Elhelaly R; Tawfik A
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):585-92. PubMed ID: 25769098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
    Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
    Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal vein thrombosis in cirrhosis.
    Raja K; Jacob M; Asthana S
    J Clin Exp Hepatol; 2014 Dec; 4(4):320-31. PubMed ID: 25755579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis.
    Rugivarodom M; Charatcharoenwitthaya P
    J Clin Transl Hepatol; 2020 Dec; 8(4):432-444. PubMed ID: 33447527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis.
    Naeshiro N; Aikata H; Hyogo H; Kan H; Fujino H; Kobayashi T; Fukuhara T; Honda Y; Nakahara T; Ohno A; Miyaki D; Murakami E; Kawaoka T; Tsuge M; Hiraga N; Hiramatsu A; Imamura M; Kawakami Y; Ochi H; Chayama K
    Hepatol Res; 2015 Jun; 45(6):656-62. PubMed ID: 25088236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
    Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X
    Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture.
    Gîrleanu I; Trifan A; Stanciu C; Sfarti C
    World J Gastroenterol; 2018 Oct; 24(39):4419-4427. PubMed ID: 30356984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.
    Luca A; Miraglia R; Caruso S; Milazzo M; Sapere C; Maruzzelli L; Vizzini G; Tuzzolino F; Gridelli B; Bosch J
    Gut; 2011 Jun; 60(6):846-52. PubMed ID: 21357252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors].
    Lin GS; Xu Q; Zhao SY; Zhang YX
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):513-517. PubMed ID: 27784429
    [No Abstract]   [Full Text] [Related]  

  • 17. [Correlational study on portal vein thrombosis of liver cirrhosis].
    Xu DQ; Yang JH
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):573-579. PubMed ID: 32791792
    [No Abstract]   [Full Text] [Related]  

  • 18. A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis.
    Rodriguez-Castro KI; Vitale A; Fadin M; Shalaby S; Zerbinati P; Sartori MT; Landi S; Pettinari I; Piscaglia F; Han G; Burra P; Simioni P; Senzolo M
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):34-42. PubMed ID: 30188408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation against portal vein thrombosis reduces mortality and liver cirrhosis-related complications: A propensity score-matched study.
    Sato A; Watanabe S; Iseki M; Yamada Y; Kobayashi R; Furuya M; Arai K; Ohshina E; Tashiro Y; Nozaka T; Matsuoka M; Yauchi M; Kobayashi K; Matsumoto T; Furumoto Y; Asano T; Azuma S
    Hepatol Res; 2023 Nov; 53(11):1096-1104. PubMed ID: 37435880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
    Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G
    Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.